Amid rising cases of the novel coronavirus (Covid-19), the captains of Indian pharma industry on Friday said there was no reason to panic over drug supplies in the domestic market. The industry, however, was unanimous that high level of dependence on one geography for key raw materials had to be reduced to mitigate risks.
Meanwhile, Gujarat-based Cadila Healthcare has launched an accelerated research programme for developing a vaccine for Covid-19 with multiple teams in India and Europe. Pankaj R Patel, chairman of Cadila Healthcare, said the vaccine candidate should be ready in 8-10 months with support from the regulators. “We felt